Recent Insights » Case Studies » Global Osteoarthritis Program facing FDA Safety Concerns

× Share this Presentation

Facebook
Twitter
Email
LinkedIn

Global Osteoarthritis Program facing FDA Safety Concerns

February 1, 2019

Share this Flipbook
Facebook
Twitter
Email
LinkedIn

Previous Flipbook

How a Sponsor Secured 200 High-Performing PI's in a New TA in Just 5 Days

Next Flipbook

Finding an Agile PV Partner for Early-Stage Clinical Development

Most Recent Flipbooks

WCG Independent Site Network For Sites

Case Study

WCG Case Study - Alleviating Critical Staffing Challenges for Cedars-Sinai

Case Study

Partnering with WCG Saved Small Biotech Over $12K Each Month

Case Study

WCG’s PV Services Smooths Path to Approval for Emerging Biopharma

Case Study

WCG MRS Case Study - Franciscan Health

Case Study

Case Study - Leading Sponsor Delivers Enrollment 24 Months Ahead of Schedule With WCG Site Augmentation

Case Study

Post-Partum Depression Case Study: WCG Services for CNS Trials

Case Study

Movement Disorder Case Study: WCG Services for CNS Trials

Case Study

WCG Velos Case Study - Cancer Center

Case Study

Case Study - Avoca CQMS Consulting

Case Study

Case Study - Avoca Mock Inspection Consulting

Case Study

Case Study - WCG Helps Sponsor Secure 200 Investigators in 5 Days

Case Study

Case Study - Eliminating 98,166 Hours of Redundant Study Training

Case Study

Case Study - Making Study Training More Effective and Engaging for Endo

Case Study

WCG Supports Small Oncology Biotech Through Rapid Growth, Saving Hundreds of Thousands of Dollars

Case Study

Case Study - Leading Pharma Enrolls 56% Faster with WCG Site Augmentation

Case Study

Helping Your Sites Meet Their Full Potential in Oncology

Case Study

Case Study - Top 5 Sponsor Enrolls 30,000+ Patients in Just Over 3 Months With WCG Site Augmentation

Case Study

How WCG Statistics Collaborative Helped Breakthrough Therapy Obtain Regulatory Approval

Case Study

See How WCG Helped a Mid-tier Biopharma Respond to an Urgent FDA Request, and Adjudicate 400 Endpoints in Just a Few Short Weeks

Case Study

Return to Home